Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia

NCT00268229 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: cytarabine
DRUG: daunorubicin hydrochloride
DRUG: imatinib mesylate

Sponsor

The Cleveland Clinic

Collaborators

[object Object]